EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer

doi:10.3892/or.2017.5442

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 食品科技系 > 期刊論文 > Item 310902800/31743

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/31743

標題:	EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer
作者:	Sun, Ding-Ping Fang, Chia-Lang Chen, Han-Kun Wen, Kuo-Shan Hseu, You-Cheng Hung, Shih-Ting Uen, Yih-Huei Lin, Kai-Yuan
貢獻者:	Chi Mei Med Ctr, Dept Surg Chi Mei Med Ctr, Dept Pharm Chi Mei Med Ctr, Dept Med Res Chia Nan Univ Pharm & Sci, Dept Food Sci & Technol Chia Nan Univ Pharm & Sci, Dept Biotechnol Taipei Med Univ, Sch Med, Dept Pathol, Coll Med Taipei Med Univ, Dept Pathol, Wan Fang Hosp China Med Univ, Dept Cosmeceut Asia Univ, Dept Hlth & Nutr Biotechnol Chi Mei Hosp Chiali, Superintendents Off
關鍵字:	exchange protein directly activated by cAMP gastric cancer prognosis
日期:	2017-04
上傳時間:	2018-11-30 15:55:02 (UTC+8)
出版者:	Spandidos Publ Ltd
摘要:	cAMP signaling controls a variety of cellular functions. In addition to the well-known signal transducer cAMP-dependent protein kinase, a more recently discovered transducer is the exchange protein directly activated by cAMP (EPAC). EPAC responses are mediated by small G proteins, which regulate biologic functions such as cell adhesion, migration and proliferation. Recently, the clinical importance of EPAC1 has received increased attention. This study investigated the correlations between the expression of EPAC1 and various clinicopathologic parameters as well as the survival of the patients with gastric cancer (GC). The patient cohort in this study consisted of 141 cases of GC that presented from 1999 through 2011; documented clinicopathologic parameters and clinical outcomes were available for all cases. Immunoblotting, immunohistochemistry and quantitative real-time PCR were used to examine EPAC1 expression in gastric cells and tissues. siRNA technology was used to study the effect of EPAC1 knockdown on cell proliferation and invasion. An increase in EPAC1 expression was found in GC cells and tissues. The overexpression of EPAC1 was associated with the depth of invasion (P=0.0021), stage (P=0.0429), and vascular invasion (P=0.0049) and was correlated with poor disease-free survival (P=0.0029) and overall survival (P=0.0024). A univariate Cox regression analysis showed that the overexpression of EPAC1 was a prognostic marker for GC (P=0.038). Furthermore, cell studies indicated that the knockdown of EPAC1 in GC cells suppressed cell proliferation and invasion. The overexpression of EPAC1 can be used as a marker to predict the outcome of patients with GC, and EPAC1 represents a potential therapeutic modality for treating
關聯:	Oncology Reports, v.37, n.4, pp.1953-1960
显示于类别:	[生物科技系(所)] 期刊論文 [ 食品科技系 ] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
index.html		0Kb	HTML	1594	检视/开启
or.2017.5442.pdf		626Kb	Adobe PDF	0	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....